Cardax Reports Q3 2017 Results

HONOLULU, Nov. 14, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced strong ZanthoSyn® revenues of approximately $322,000 for the third quarter of 2017 — up nearly 5 times from the second quarter of 2017, as reported in the Company's Form 10-Q filed today.These results include...